Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Year-over-year earnings per share growth rate
Latest
0.00%
↑ 100% vs avg
Percentile
P52
Within normal range
Streak
1 qtr
Consecutive growthStable
Average
-0.06%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | -10.71% |
| Q2 2025 | 0.00% |
| Q1 2025 | 9.68% |
| Q4 2024 | 11.43% |
| Q3 2024 | -139.33% |
| Q2 2024 | 306.98% |
| Q1 2024 | -7.50% |
| Q4 2023 | -2.56% |
| Q3 2023 | -2.63% |
| Q2 2023 | -5.56% |
| Q1 2023 | 20.00% |
| Q4 2022 | 13.46% |
| Q3 2022 | 37.35% |
| Q2 2022 | -29.69% |
| Q1 2022 | -10.34% |
| Q4 2021 | -1.75% |
| Q3 2021 | 5.00% |
| Q2 2021 | -11.11% |
| Q1 2021 | 15.62% |
| Q4 2020 | 8.57% |
| Q3 2020 | -6.06% |
| Q2 2020 | 18.52% |
| Q1 2020 | -14.08% |
| Q4 2019 | 23.66% |
| Q3 2019 | -66.07% |
| Q2 2019 | 64.56% |
| Q1 2019 | -203.85% |
| Q4 2018 | 1.89% |
| Q3 2018 | -15.22% |
| Q2 2018 | -12.20% |
| Q1 2018 | 0.00% |